47120 Federal Register / Vol. 86, No. 160 / Monday, August 23, 2021 / Notices 

Provider Relief Programs disbursed, and 

are continuing to disburse, funds to 

eligible healthcare providers through 

two pathways: (1) Direct provider 

payments via the PRF and ARPA–R 

payments, and (2) claims 

reimbursement via the CAF and the UIP. 

This information collection includes 

four components: (1) The PRF and 

ARPA–R application portal; (2) the PRF 

and ARPA–R attestation portal; (3) the 

CAF application portal; and (4) the UIP 

application portal. To date, information 

for these programs has been collected 

under a Paperwork Reduction Act 

waiver executed pursuant to public 

health emergency authorities. HRSA is 

seeking comments regarding the CAF 

and the UIP for the first time. These 

information collections support 

administration of the Provider Relief 

Programs including the PRF, the 

Uninsured Program, and the CAF (funds 

for these three programs were 

appropriated under the Coronavirus 

Aid, Relief, and Economic Security Act 

(Pub. L. 116–136), Paycheck Protection 

Program and Health Care Enhancement 

Act (Pub. L. 116–139), Coronavirus 

Response and Relief Supplemental 

Appropriations Act (Division M of Pub. 

L. 116–260)), and the ARPA–R 

payments (funds were appropriated 

under the American Rescue Plan Act of 

2021, Pub. L. 117–2). 

Need and Proposed Use of the 

Information: Providers who apply for 

Provider Relief Programs (i.e., PRF, 

ARPA–R, CAF, and UIP payments) must 

apply for direct provider payments or 

claims reimbursement and attest to a set 

of Terms and Conditions to enable 

HRSA’s appropriate disbursement and 

oversight of recipients’ use of funds. 

Information collected will allow for 

(1) assessing if recipients have met 

statutory and programmatic 

requirements; (2) conducting audits; (3) 

gathering data required to calculate, 

disburse, and report on PRF, ARPA–R, 

CAF, and UIP payments; and (4) 

program evaluation. HRSA staff may 

also use information collected to 

identify and report on trends in the 

effect of the COVID–19 pandemic on 

health care providers and uninsured or 

underinsured patients throughout the 

United States. 

HHS makes publicly available the 

names of payment recipients and the 

aggregate amounts received, for all 

providers who attest to receipt of a 

payment and acceptance of the Terms 

and Conditions or who retain payments 

for more than 90 days and are deemed 

to have accepted the Terms and 

Conditions. By accepting funds, the 

recipient consents to HHS publicly 

disclosing the payments that recipient 

has received. 

Likely Respondents: Health care 

providers that apply to receive, or have 

applied to receive, PRF, ARPA–R, CAF, 

or UIP payments, and attested to the 

associated Terms and Conditions. 

Burden Statement: Burden in this 

context means the time expended by 

persons to generate, maintain, retain, 

disclose, or provide the information 

requested. This includes the time 

needed to review instructions; to 

develop, acquire, install, and utilize 

technology and systems for the purpose 

of collecting, validating, and verifying 

information, processing and 

maintaining information, and disclosing 

and providing information; to train 

personnel and to be able to respond to 

a collection of information; to search 

data sources; to complete and review 

the collection of information; and to 

transmit or otherwise disclose the 

information. The total annual burden 

hours estimated for this ICR are 

summarized in the table below. 

Total Estimated Annualized Burden 

Hours: 

Form name Number of 

respondents 

Number of 

responses per 

respondent 

Total 

responses 

Average 

burden per 

response 

(in hours) 

Total burden 

hours 

Attestation Portal .................................................................. 130,000 1 130,000 0.25 32,500 

Application Portal ................................................................. 130,000 1 130,000 1.00 130,000 

CAF Application ................................................................... 15,000 1 15,000 1.00 15,000 

UIP Application .................................................................... 280,000 1 280,000 5.60 1,568,000 

Total .............................................................................. 555,000 ........................ 555,000 ........................ 1,745,500 

HRSA specifically requests comments 

on (1) the necessity and utility of the 

proposed information collection for the 

proper performance of the agency’s 

functions; (2) the accuracy of the 

estimated burden; (3) ways to enhance 

the quality, utility, and clarity of the 

information to be collected; and (4) the 

use of automated collection techniques 

or other forms of information 

technology to minimize the information 

collection burden. 

Maria G. Button, 

Director, Executive Secretariat. 

[FR Doc. 2021–18018 Filed 8–20–21; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Information Technology 

Advisory Committee 2021 Schedule of 

Meetings 

AGENCY: Office of the National 

Coordinator for Health Information 

Technology (ONC), HHS. 

ACTION: Notice of meetings. 

SUMMARY: The Health Information 

Technology Advisory Committee 

(HITAC) was established in accordance 

with the 21st Century Cures Act and the 

Federal Advisory Committee Act. The 

HITAC, among other things, identifies 

priorities for standards adoption and 

makes recommendations to the National 

Coordinator for Health Information 

Technology (National Coordinator). The 

HITAC will hold public meetings 

throughout 2021. See list of public 

meetings below. 

FOR FURTHER INFORMATION CONTACT: 

Michael Berry, Designated Federal 

Officer, at Michael.Berry@hhs.gov, (202) 

701–0795. 

SUPPLEMENTARY INFORMATION: Section 

4003(e) of the 21st Century Cures Act 

(Pub. L. 114–255) establishes the Health 

Information Technology Advisory 

Committee (referred to as the ‘‘HITAC’’). 

The HITAC will be governed by the 

provisions of the Federal Advisory 

Committee Act (FACA) (Pub. L. 92– 

463), as amended, (5 U.S.C. App.), 

which sets forth standards for the 

formation and use of federal advisory 

committees. 

Composition 

The HITAC is comprised of at least 25 

members, of which: 


jbell on DSKJLSW7X2PROD with NOTICES
Federal Register / Vol. 86, No. 160 / Monday, August 23, 2021 / Notices 47121 

• No fewer than 2 members are 

advocates for patients or consumers of 

health information technology; 

• 3 members are appointed by the 

HHS Secretary 

Æ 1 of whom shall be appointed to 

represent the Department of Health and 

Human Services and 

Æ 1 of whom shall be a public health 

official; 

• 2 members are appointed by the 

majority leader of the Senate; 

• 2 members are appointed by the 

minority leader of the Senate; 

• 2 members are appointed by the 

Speaker of the House of Representatives; 

• 2 members are appointed by the 

minority leader of the House of 

Representatives; and 

• Other members are appointed by 

the Comptroller General of the United 

States. 

Members will serve for one-, two-, or 

three-year terms. All members may be 

reappointed for a subsequent three-year 

term. Each member is limited to two 

three-year terms, not to exceed six years 

of service. Members serve without pay, 

but will be provided per-diem and 

travel costs for committee services, if 

warranted. 

Recommendations 

The HITAC recommendations to the 

National Coordinator are publicly 

available at https://www.healthit.gov/ 

topic/federal-advisory-committees/ 

recommendations-national-coordinatorhealth-it. 

Public Meetings 

The schedule of meetings to be held 

in 2021 is as follows: 

• January 13, 2021 from approximately 

9:30 a.m. to 2:30 p.m./Eastern Time 

(virtual meeting) 

• February 10, 2021 from approximately 

9:30 a.m. to 2:30 p.m./Eastern Time 

(virtual meeting) 

• March 10, 2021 from approximately 

9:30 a.m. to 2:30 p.m./Eastern Time 

(virtual meeting) 

• April 15, 2021 from approximately 

9:30 a.m. to 2:30 p.m./Eastern Time 

(virtual meeting) 

• May 13, 2021 from approximately 

9:30 a.m. to 2:30 p.m./Eastern Time 

(virtual meeting) 

• June 9, 2021 from approximately 9:30 

a.m. to 2:30 p.m./Eastern Time 

(virtual meeting) 

• July 14, 2021 from approximately 9:30 

a.m. to 2:30 p.m./Eastern Time 

(virtual meeting) 

• September 9, 2021 from 

approximately 9:30 a.m. to 2:30 p.m./ 

Eastern Time (virtual meeting) 

• October 13, 2021 from approximately 

9:30 a.m. to 2:30 p.m./Eastern Time 

(virtual meeting) 

• November 10, 2021 from 

approximately 9:30 a.m. to 2:30 p.m./ 

Eastern Time (virtual meeting) 

All meetings are open to the public. 

Additional meetings may be scheduled 

as needed. For web conference 

instructions and the most up-to-date 

information, please visit the HITAC 

calendar on the ONC website, https://

www.healthit.gov/topic/federaladvisory-committees/hitac-calendar. 

Contact Person for Meetings: Michael 

Berry, Michael.Berry@hhs.gov. A notice 

in the Federal Register about last 

minute modifications that impact a 

previously announced advisory 

committee meeting cannot always be 

published quickly enough to provide 

timely notice. Please email Michael 

Berry for the most current information 

about meetings. 

Agenda: As outlined in the 21st 

Century Cures Act, the HITAC will 

develop and submit recommendations 

to the National Coordinator on the 

topics of interoperability, privacy and 

security, and patient access. In addition, 

the committee will also address any 

administrative matters and hear 

periodic reports from ONC. ONC 

intends to make background material 

available to the public no later than 24 

hours prior to the meeting start time. If 

ONC is unable to post the background 

material on its website prior to the 

meeting, the material will be made 

publicly available on ONC’s website 

after the meeting, at http://

www.healthit.gov/hitac. 

Procedure: Interested persons may 

present data, information, or views, 

orally or in writing, on issues pending 

before the committee. Written 

submissions may be made to the contact 

person prior to the meeting date. An 

oral public comment period will be 

scheduled at each meeting. Time 

allotted for each commenter will be 

limited to three minutes. If the number 

of speakers requesting to comment is 

greater than can be reasonably 

accommodated during the scheduled 

public comment period, ONC will take 

written comments after the meeting. 

Persons attending in-person HITAC 

meetings are advised that the agency is 

not responsible for providing wireless 

access or access to electrical outlets. 

ONC welcomes the attendance of the 

public at its HITAC meetings. Seating is 

limited at in-person meetings, and ONC 

will make every effort to accommodate 

persons with physical disabilities or 

special needs. If you require special 

accommodations due to a disability, 

please contact Michael Berry at least 

seven (7) days in advance of the 

meeting. 

Notice of these meetings are given 

under the Federal Advisory Committee 

Act (Pub. L. No. 92–463, 5 U.S.C., App. 

2). 

Dated: July 27, 2021. 

Michael Berry, 

Designated Federal Officer, Office of the 

National Coordinator for Health Information 

Technology. 

[FR Doc. 2021–18019 Filed 8–20–21; 8:45 am] 

BILLING CODE 4150–45–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of General Medical 

Sciences; Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

General Medical Sciences Special Emphasis 

Panel; NIGMS Review of SuRE Applications. 

Date: November 18, 2021. 

Time: 10:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Natcher Building, 45 Center Drive, Bethesda, 

MD 20892 (Video Meeting). 

Contact Person: Sonia Ortiz-Miranda, 

Ph.D., Scientific Review Officer, Office of 

Scientific Review, National Institute of 

General Medical Sciences, National Institutes 

of Health, 45 Center Drive, Room 3AN18, 

Bethesda, MD 20892, (301) 402–9448, 

sonia.ortiz-miranda@nih.gov. 

Name of Committee: National Institute of 

General Medical Sciences Special Emphasis 

Panel; NIGMS Review of SuRE Applications. 

Date: November 19, 2021. 

Time: 9:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Natcher Building, 45 Center Drive, Bethesda, 

MD 20892 (Video Meeting). 

Contact Person: Manas Chattopadhyay, 

Ph.D., Scientific Review Officer, Office of 

Scientific Review, National Institute of 

General Medical Sciences, National Institutes 

of Health, Building 45, Room 3AN12N, 45 

Center Drive, Bethesda, MD 20892, 301–827– 

5320, manasc@mail.nih.gov. 


jbell on DSKJLSW7X2PROD with NOTICES